KER Stock Analysis: Kering | PA
Luxury Goods | PA, France | Market Cap: 30.968m EUR | 12M Return: 29.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 83.4M
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Kering SA is a Paris-based luxury conglomerate that operates and develops a portfolio of premium fashion, leather goods, and jewelry houses across global markets including Asia Pacific, Western Europe, North America, and Japan. The company offers ready-to-wear, accessories, leather goods, shoes, watches, jewelry, eyewear, fragrances, and cosmetics for men and women under brands such as Gucci, Saint Laurent, Bottega Veneta, Balenciaga, Alexander McQueen, Boucheron, Pomellato, Qeelin, and Ginori 1735, alongside its in-house Kering Eyewear and Kering Beauté divisions.
The group follows a multi-brand holding structure common in the Apparel, Accessories & Luxury Goods sub-industry, retaining direct ownership of its maisons rather than relying primarily on licensing arrangements, and operating dedicated verticals for eyewear and beauty. Founded in 1963 and formerly known as PPR SA, the company adopted its current name in May 2013.
- Gucci revenue decline deepens amid brand repositioning costs
- China luxury demand weakness pressures Asia sales
- Kering Eyewear margin expansion offsets core brand drag
| Net Income: 72.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.88 > 1.0 |
| NWC/Revenue: 18.45% < 20% (prev 11.83%; Δ 6.62% < -1%) |
| CFO/TA 0.06 > 3% & CFO 2.51b > Net Income 72.0m |
| Net Debt (25.5b) to EBITDA (3.67b): 6.94 < 3 |
| Current Ratio: 1.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (122.9m) vs 12m ago 0.39% < -2% |
| Gross Margin: 72.64% > 18% (prev 73.75%; Δ -1.11% > 0.5%) |
| Asset Turnover: 34.72% > 50% (prev 39.67%; Δ -4.94% > 0%) |
| Interest Coverage Ratio: 2.59 > 6 (EBIT TTM 1.63b / Interest Expense TTM 630.0m) |
| A: 0.07 (Total Current Assets 10.8b - Total Current Liabilities 8.05b) / Total Assets 41.2b |
| B: 0.36 (Retained Earnings 14.9b / Total Assets 41.2b) |
| C: 0.04 (EBIT TTM 1.63b / Avg Total Assets 42.3b) |
| D: 0.57 (Book Value of Equity 14.7b / Total Liabilities 25.7b) |
| Altman-Z'' = 2.47 = A |
| DSRI: 1.53 (Receivables 1.31b/1.00b, Revenue 14.7b/17.2b) |
| GMI: 1.02 (GM 73.75% / 72.64%) |
| AQI: 1.15 (AQ_t 0.52 / AQ_t-1 0.45) |
| SGI: 0.85 (Revenue 14.7b / 17.2b) |
| TATA: -0.06 (NI 72.0m - CFO 2.51b) / TA 41.2b) |
| Beneish M = -2.60 (Cap -4..+1) = A |
As of July 07, 2026, the stock is trading at EUR 249.70 with a total of 248,119 shares traded. Over the past week, the price has changed by -6.00%, over one month by +0.28%, over three months by -2.04% and over the past year by +29.74%.
Current recommended Stop Loss: 236.60 (which is 5.2% or 1.3 ATR below the current price).
Kering has no consensus analysts rating.
P/E Forward = 37.7358
P/S = 2.1123
P/B = 2.0491
P/EG = 1.1232
Revenue TTM = 14.7b EUR
EBIT TTM = 1.63b EUR
EBITDA TTM = 3.67b EUR
Long Term Debt = 10.3b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.23b EUR (from shortTermDebt, last quarter)
Debt = 29.8b EUR (from shortLongTermDebtTotal, last quarter) + Leases 6.21b
Net Debt = 25.5b EUR (calculated: Debt 29.8b - CCE 4.31b)
Enterprise Value = 56.5b EUR (31.0b + Debt 29.8b - CCE 4.31b)
Interest Coverage Ratio = 2.59 (Ebit TTM 1.63b / Interest Expense TTM 630.0m)
EV/FCF = 33.57x (Enterprise Value 56.5b / FCF TTM 1.68b)
FCF Yield = 2.98% (FCF TTM 1.68b / Enterprise Value 56.5b)
FCF Margin = 11.46% (FCF TTM 1.68b / Revenue TTM 14.7b)
Net Margin = 0.49% (Net Income TTM 72.0m / Revenue TTM 14.7b)
Gross Margin = 72.64% ((Revenue TTM 14.7b - Cost of Revenue TTM 4.01b) / Revenue TTM)
Gross Margin QoQ = 72.25% (prev 73.01%)
Tobins Q-Ratio = 1.37 (Enterprise Value 56.5b / Total Assets 41.2b)
Interest Expense / Debt = 2.11% (Interest Expense 630.0m / Debt 29.8b)
Taxrate = 25.0% (non-US conservative default 25%)
NOPAT = 1.22b (EBIT 1.63b * (1 - 25.00%))
Current Ratio = 1.34 (Total Current Assets 10.8b / Total Current Liabilities 8.05b)
Debt / Equity = 2.03 (Debt 29.8b / totalStockholderEquity, last quarter 14.7b)
Debt / EBITDA = 6.94 (Net Debt 25.5b / EBITDA 3.67b)
Debt / FCF = 15.16 (Net Debt 25.5b / FCF TTM 1.68b)
Total Stockholder Equity = 14.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.17% (Net Income 72.0m / Total Assets 41.2b)
RoE = 0.49% (Net Income TTM 72.0m / Total Stockholder Equity 14.8b)
RoCE = 6.49% (EBIT 1.63b / Capital Employed (Equity 14.8b + L.T.Debt 10.3b))
RoIC = 3.43% (NOPAT 1.22b / Invested Capital 35.6b)
WACC = 4.98% (E(31.0b)/V(60.8b) * Re(8.25%) + D(29.8b)/V(60.8b) * Rd(2.11%) * (1-Tc(0.25)))
Discount Rate = 8.25% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -33.33 | Cagr: -0.66%
[DCF] Terminal Value 77.97% ; FCFF base≈1.56b ; Y1≈1.79b ; Y5≈2.64b
[DCF] Fair Price = 115.9 (EV 39.7b - Net Debt 25.5b = Equity 14.2b / Shares 122.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -82.32 | EPS CAGR: -62.94% | SUE: N/A | # QB: 0
Revenue Correlation: -99.57 | Revenue CAGR: -12.83% | SUE: N/A | # QB: 0
EPS current Quarter (2026-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=6.53 | Chg30d=-0.69% | Revisions=-36% | GrowthEPS=+50.9% | GrowthRev=+0.4%
EPS next Year (2027-12-31): EPS=9.83 | Chg30d=-0.91% | Revisions=-18% | GrowthEPS=+50.4% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: -32% (up=5, down=11)